CSF1 and ovarian carcinoma: Both the knockdown of CSF‐1 or reactivation of miR‐130b expression using the DNMT inhibitor 5‐aza‐CdR were shown to sensitize drug‐resistant ovarian cancer cells to anticancer drugs.67